Madoka Iwase
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Social Media Discourse on Breast Cancer Screening Barriers in Japanese and English: Cross-Sectional Infodemiology Study.
Journal: Journal of medical Internet research
Published: April 09, 2026
Perceived usefulness of online videos for hereditary breast cancer communication in Japan: Patient and provider perspectives.
Journal: Public health in practice (Oxford, England)
Published: March 03, 2026
Extracellular vesicles in nipple discharge for breast cancer screening.
Journal: Breast cancer research and treatment
Published: February 22, 2026
Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.
Journal: Breast cancer (Tokyo, Japan)
Published: August 18, 2025
A Case Report of Surgical and Postoperative Treatment for Thyroid Angiosarcoma with Pulmonary Metastasis.
Journal: Surgical case reports
Published: June 16, 2025
Correction to: Prognostic impact of ER‑staining patterns and heterogeneity of ER positive HER2 negative breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: June 09, 2025
Clinical and Pathological Characteristics and Treatment Implications of BRCA1- and BRCA2-Mutated Breast Cancer in Japanese Patients: A Single-Institution Retrospective Study.
Journal: Breast cancer : basic and clinical research
Published: May 18, 2025
Prognostic impact of ER-staining patterns and heterogeneity of ER positive HER2 negative breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: December 06, 2024
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast.
Journal: Breast cancer (Tokyo, Japan)
Published: December 04, 2024
Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).
Journal: Breast cancer (Tokyo, Japan)
Published: December 03, 2024
Assessing the quality of Japanese online breast cancer treatment information using large language models: a comparison of ChatGPT, Claude, and expert evaluations.
Journal: Breast cancer (Tokyo, Japan)
Published: November 20, 2024
Last Updated: 09/26/2026